There have been advances in the
field of biologics that enable scientists to synthetically modify recombinant
proteins and monoclonal antibodies and use them in therapeutics, diagnostics
and other fields. Thanks to bioconjugation,
these biomolecules can be used to reveal enzyme function, to track cellular
events, to determine protein biodistribution, to image specific biomarkers, and
to deliver drugs to specific cells.
